Last reviewed · How we verify

Treatment of TongBi Capsule — Competitive Intelligence Brief

Treatment of TongBi Capsule (Treatment of TongBi Capsule) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Respiratory.

phase 3 Traditional Chinese medicine Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Treatment of TongBi Capsule (Treatment of TongBi Capsule) — Guang'anmen Hospital of China Academy of Chinese Medical Sciences. TongBi Capsule is used to treat symptoms of chronic bronchitis and asthma by improving lung function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Treatment of TongBi Capsule TARGET Treatment of TongBi Capsule Guang'anmen Hospital of China Academy of Chinese Medical Sciences phase 3 Traditional Chinese medicine
Yangxinshi tablet simulants Yangxinshi tablet simulants Dongzhimen Hospital, Beijing marketed Traditional Chinese medicine herbal formulation
Placebo of Gastrodia and Uncaria granule Placebo of Gastrodia and Uncaria granule Shanghai Institute of Hypertension marketed Herbal medicine / Traditional Chinese medicine
Abelmoschus manihot (AM) Abelmoschus manihot (AM) Chinese PLA General Hospital marketed Herbal extract / Traditional Chinese Medicine
Louxiangdan Tongxin granules Louxiangdan Tongxin granules Liaoning University of Traditional Chinese Medicine marketed Traditional Chinese medicine herbal formulation
Erigeron breviscapus injection Erigeron breviscapus injection Guangzhou University of Traditional Chinese Medicine marketed Traditional Chinese medicine extract; antiplatelet/microcirculation enhancer
Twice Normal-dose Wenxin Granules Twice Normal-dose Wenxin Granules China Academy of Chinese Medical Sciences marketed Traditional Chinese medicine herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

  1. Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
  2. Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
  3. Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
  4. Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
  5. Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
  6. China Academy of Chinese Medical Sciences · 1 drug in this class
  7. The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
  8. Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Treatment of TongBi Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-of-tongbi-capsule. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: